CVS Health plans to split into two companies, shares down
BUZZ-CVS Health plans to split into two companies, shares down Updates
** Shares of health insurer CVS Health CVS.N fall 11.9% to $80.58
** Company plans to separate into two independent, publicly traded companies, with completion targeted for the first half of 2028
** CVS Health CEO David Joyner will lead the insurance and health-services company, while Group President Prem Shah will become CEO of CVS Pharmacy; shareholders will own stock in both companies
** Leerink Partners cited deal-related factors and broader volatility following the US midterm elections as potential reasons behind the stock slide
** Separately, CVS reports Q3 adjusted EPS of $2.09, above analysts' estimate of $1.65 - data compiled by LSEG
** Raises 2026 adjusted EPS forecast to at least $8.20 from $7.90-$8.10
** "Despite the strong operational results, we expect the stock today to react more to the election results last night and the potential implications of the split on near-term shareholder value" - UBS analyst Kevin Caliendo
** Including session's move, CVS up 1.5% YTD
(Reporting by Kunal Das in Bengaluru)
Recent news on CVS Health
See all newsHealth Rounds: GLP-1 drugs tied to heart improvements in patients with obesity and heart failure
US health insurers fall for third day on CMS audit proposal, Medicare-for-All concerns
Health insurers extend decline on proposed new rule to curb fraud
Health insurers extend decline on proposed new rule to curb fraud
UnitedHealthcare to expand program paying pharmacists for medical services